Channels - Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized Oncology

Similar Items: Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized Oncology

Quick Look
Prognostic and therapeutic roles of specific genotypes through target-gene sequencing on gastroenteropancreatic neuroendocrine carcinoma
Quick Look
Multimodal management of hormonal and oncological progression in PTHrP-secreting pancreatic neuroendocrine tumours
Quick Look
Metastatic neuroendocrine lesions in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): a narrative review and case series
Quick Look
Patient-reported symptom and urgent healthcare use in neuroendocrine tumors
Quick Look
Mesenteric paraganglioma mimicking nodal metastasis of an occult small intestinal neuroendocrine tumor
Quick Look
ATA 2015-2025 risk stratification transition: prognostic significance of N1b disease in papillary thyroid carcinoma with limited nodal burden
Quick Look
Still human: Presence, oncology, and artificial intelligence
Quick Look
Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?
Quick Look
Robust response to pembrolizumab in temozolomide-associated hypermutated and microsatellite instability-high functional pancreatic neuroendocrine tumor
Quick Look
Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts
Quick Look
Withstanding the test of time for patients in oncology clinical trials
Quick Look
Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation
Quick Look
Reviewer Acknowledgements for Cancer and Clinical Oncology, Vol. 8, No. 1
Quick Look
Skin health in oncology: evidence-based skin care for cancer patients
Quick Look
Optimal management of venous thromboembolism in adolescent and young adult oncology patients
Quick Look
Primary tumor size as a prognostic factor in duodenal neuroendocrine neoplasms ≤20 mm: a population-based SEER analysis
Quick Look
Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma
Quick Look
Enhancing Oncological Care for India's Aging Population: Addressing the Complex Needs of Older Adults With Cancer
Quick Look
Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer
Quick Look
Clinical and biological aspects of aggressive B-cell non-Hodgkin lymphoma in adolescents and young adults
Quick Look
Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experience
Quick Look
Shifting a paradigm: highlights of model informed drug development in dosage selection and optimization for oncology products
Quick Look
Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancer
Quick Look
SGO1 and SGO2 are Associated With Disease Progression and an Immunosuppressive Microenvironment in Papillary Renal Cell Carcinoma